-
521
Construction of a Vero cell line expression human KREMEN1 for the development of CVA6 vaccines
Published 2025-01-01Subjects: Get full text
Article -
522
Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development
Published 2025-01-01Subjects: Get full text
Article -
523
-
524
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)
Published 2025-02-01Subjects: Get full text
Article -
525
Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis
Published 2025-01-01Subjects: Get full text
Article -
526
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Published 2025-01-01Subjects: Get full text
Article -
527
The Role of Partnerships in Supporting COVID-19 Vaccine Uptake Among Migrants: A Qualitative Case Study from Tamil Nadu and Punjab, India
Published 2025-01-01Subjects: Get full text
Article -
528
Tissue‐resident memory T cells in diseases and therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article -
529
Impact of COVID-19 vaccinations in India: a state-wise analysis
Published 2025-01-01Subjects: Get full text
Article -
530
-
531
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
532
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against Mycobacterium avium complex subspecie...
Published 2025-03-01Subjects: “…Viral vectored vaccines…”
Get full text
Article -
533
Modern approaches to production of safe and effective genetically modified rabies vaccines for animals
Published 2023-03-01Subjects: “…genetically modified rabies vaccines…”
Get full text
Article -
534
Perspectives on AI-based recommendations for mask-wearing and COVID-19 vaccination for transplant recipients in the post-COVID-19 era
Published 2024-12-01Subjects: Get full text
Article -
535
Development of a Recombinant Fusion Vaccine Candidate Against Lethal <i>Clostridium botulinum</i> Neurotoxin Types A and B
Published 2025-01-01Subjects: Get full text
Article -
536
Medicinal products used for the treatment and prophylaxis of COVID-19
Published 2020-06-01Subjects: Get full text
Article -
537
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse...
Published 2025-12-01Subjects: “…Malaria vaccine…”
Get full text
Article -
538
Experience of COVID-19 vaccination among healthcare workers in Iran: a descriptive phenomenological study
Published 2025-01-01Subjects: Get full text
Article -
539
Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer
Published 2025-01-01Subjects: Get full text
Article -
540
Editorial: Antigen presentation in cancer immune responses
Published 2025-01-01Subjects: Get full text
Article